In 2016-17, the exports decreased by 0.43 per cent in value terms and 6.95 per cent in volume terms, Minister of State for Commerce and Industry C R Chaudhary said in a written reply to a question in the Rajya Sabha.
He said some of the reasons cited for a decline in exports include absence of blockbuster drugs going off-patent; consolidation of buyers in the US into three large groups with significant bargaining power; and some of the Indian companies shifting their manufacturing bases to the EU, US and other markets.
The minister also said that large number of Abbreviated New Drugs Applications were approved by the USFDA which resulted in increased competition in the generic market and led to price drops.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.